Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on dynamic resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced crystallization-induced dynamic resolution for antiviral nucleotide analogs. Enhances purity and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN104178548A details high-purity S-2-naphthylethylamine synthesis via lipase. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing.
Novel dynamic kinetic resolution method for R-2-naphthylethylamine. High yield, 99% ee. Cost-effective nickel catalyst. Reliable supply chain partner.
Patent CN104152525A reveals dynamic kinetic resolution for R-1-phenylethylamine. Achieve high yield and purity with cost-effective Raney nickel catalysts for supply chain stability.
Patent CN104178546A details high-yield enzymatic resolution for S-1-naphthylethylamine. Offers superior purity and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN104164470B details a novel DKR method for R-1-naphthylethylamine using Raney Nickel. This approach ensures high yield and purity for reliable pharmaceutical intermediates supply chains.
Patent CN104151171B details nickel-catalyzed dynamic kinetic resolution for high yield chiral amine production ensuring supply chain stability and cost efficiency.
Patent CN105017035B details a high-purity DKR method for chiral intermediates. Achieves >99% ee with scalable catalysts for reliable pharmaceutical supply chains.
Patent CN114014787B details a high-purity asymmetric route for florfenicol intermediates, offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Patent CN104263796A details a high-yield chiral synthesis route. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing globally.
Patent CN104557911B reveals enzymatic deracemization for levo-praziquantel. Achieve high optical purity and cost reduction in pharmaceutical intermediates manufacturing with scalable green chemistry.
Patent CN103288630A details a novel synthesis of Sodium Danshensu from L-Tyrosine. This report analyzes the DKR strategy for cost-effective, high-purity API intermediate manufacturing.
Patent CN101735085A details a high-yield D-serine synthesis using dynamic kinetic resolution, offering significant cost reduction and supply stability for pharmaceutical intermediates.
Patent CN109761984B details a novel ruthenium-catalyzed asymmetric hydrogen transfer method for synthesizing chiral purine nucleosides with high enantioselectivity and mild conditions.
Patent CN109761984B reveals a novel asymmetric hydrogen transfer method for high-purity chiral purine nucleosides, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN110452150B details a mild, one-step synthesis of axial chiral indole-naphthalenes with high enantioselectivity, offering cost-effective solutions for chiral catalyst manufacturing.
Novel organocatalytic method for high-purity axial chiral indole-naphthalenes. Efficient scale-up and cost-effective production for asymmetric catalysis applications.
Patent CN110452150B details a novel one-step synthesis of axial chiral indole-naphthalenes using chiral phosphoric acid, offering high enantioselectivity and scalable manufacturing for advanced catalytic applications.
Novel organocatalytic route for high-purity axial chiral indole-naphthalenes. Cost-effective, scalable process for asymmetric catalysis intermediates.
Reduce production costs and environmental impact with >98% ee and 92% yield in asymmetric synthesis of key florfenicol intermediate for pharmaceutical manufacturing.